Literature DB >> 29717926

Association of Dietary Intakes of Total Polyphenol and Its Subclasses with the Risk of Metabolic Syndrome: Tehran Lipid and Glucose Study.

Gobon Sohrab1, Samira Ebrahimof2, Somayeh Hosseinpour-Niazi2, Emad Yuzbashian2, Parvin Mirmiran1, Fereidoun Azizi3.   

Abstract

BACKGROUND: The purpose of the present study was to investigate the longitudinal association of total polyphenol and its main four subclasses intake with metabolic syndrome (MetS) and its components.
METHODS: The present prospective study was conducted on 1265 Tehranian adults, aged 19-74 years. Usual dietary intake was evaluated using a validated food-frequency questionnaire. MetS was defined using NCEP ATP III guidelines. Intakes of total polyphenol and its four main subclasses, including flavonoids, phenolic acids, stilbenes, and lignans, were estimated using Phenol-Explorer database.
RESULTS: Median (interquartile range [IQR]) of total polyphenol intake and its subclasses, including flavonoids, phenolic acids, lignans, and stilbenes, was 1422 (967-2137), 69.5 (45.5-99.8), 75.7 (52.2-115), 3.8 (1.9-6.9), and 0.2 (0.1-0.5) mg/day, respectively. After adjustment for confounding factors, participants in the highest tertile of flavonoid intake had 31% lower risk of developing MetS (odds ratio [OR] 0.69; 95% CI 0.48-0.98) and 36% lower risk of hypertriglyceridemia (OR 0.64; 95% CI 0.48-0.99) during 6 years of follow-up. Total polyphenol intake and other subclasses of polyphenol were not associated with MetS and its components.
CONCLUSION: Higher intake of flavonoids was inversely associated with risk of developing MetS and hypertriglyceridemia in a Tehranian population.

Entities:  

Keywords:  flavonoids; metabolic syndrome; polyphenols

Mesh:

Substances:

Year:  2018        PMID: 29717926     DOI: 10.1089/met.2017.0140

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  5 in total

1.  Polyphenol intake and metabolic syndrome risk in European adolescents: the HELENA study.

Authors:  Ratih Wirapuspita Wisnuwardani; Stefaan De Henauw; Maria Forsner; Frédéric Gottrand; Inge Huybrechts; Viktoria Knaze; Mathilde Kersting; Cinzia Le Donne; Yannis Manios; Ascensión Marcos; Dénes Molnár; Joseph A Rothwell; Augustin Scalbert; Michael Sjöström; Kurt Widhalm; Luis A Moreno; Nathalie Michels
Journal:  Eur J Nutr       Date:  2019-03-22       Impact factor: 5.614

Review 2.  Lignan exposure: a worldwide perspective.

Authors:  Lucia Rizzolo-Brime; Elida M Caro-Garcia; Cynthia A Alegre-Miranda; Mireia Felez-Nobrega; Raul Zamora-Ros
Journal:  Eur J Nutr       Date:  2021-11-20       Impact factor: 5.614

3.  Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial.

Authors:  Zahra Yari; Makan Cheraghpour; Azita Hekmatdoost
Journal:  Eur J Nutr       Date:  2020-04-15       Impact factor: 5.614

Review 4.  Effects of the Treatment with Flavonoids on Metabolic Syndrome Components in Humans: A Systematic Review Focusing on Mechanisms of Action.

Authors:  Henrique J C B Gouveia; Mercedes V Urquiza-Martínez; Raul Manhães-de-Castro; Bárbara J R Costa-de-Santana; José Pérez Villarreal; Rosalío Mercado-Camargo; Luz Torner; Jailane de Souza Aquino; Ana E Toscano; Omar Guzmán-Quevedo
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

5.  Dose-Dependent Increases in Ellagitannin Metabolites as Biomarkers of Intake in Humans Consuming Standardized Black Raspberry Food Products Designed for Clinical Trials.

Authors:  Kristen M Roberts; Elizabeth M Grainger; Jennifer M Thomas-Ahner; Alice Hinton; Junnan Gu; Ken Riedl; Yael Vodovotz; Ronney Abaza; Steven J Schwartz; Steven K Clinton
Journal:  Mol Nutr Food Res       Date:  2020-03-17       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.